Nav: Home

Developing a new AI breast cancer diagnostic tool

December 02, 2019

Scientists are developing a new way to identify the unique chemical 'fingerprints' for different types of breast cancers.

These new chemical footprints will be used to train AI software - creating a new tool for rapid and accurate diagnosis of breast cancers.

The team of researchers from Lancaster University and Airedale NHS Foundation Trust are using a specialised chemical analytical technique called Raman Spectroscopy on biopsies to identify the molecular structure of different types of breast cancer, as well as variations within each cancer cell group.

Raman analysis is able to provide real-time information on cells and can be used to check how the cells are behaving, spreading and emerging elsewhere in the body.

After identifying the chemical fingerprints of breast cancer cells, and observing how they change, the researchers used this information to train complex machine learning algorithms to identify four subtypes of cancer.

The algorithms successfully predicted diagnostic patterns for each subtype with a high level of accuracy ranging between 70 per cent and 100 per cent.

Similar versions of these algorithms have previously been used to identify other forms of caners and diseases such as skin, oral and lung cancers.

The next stage of the research will look at creating databases of the chemical structures of many more different types of breast cancer cells and the forms they can take.

These databases will be then used to train more artificial intelligent algorithms using machine learning - eventually leading to a new diagnostic tool to sit alongside mammograms and MRI scans.

The new algorithms promise to provide rapid information to help medical specialists to make quicker diagnosis.

In addition, the approach will help to determine the state of the disease at various points in its progression and will become critical in planning the therapeutic approach of individual patients.

Professor Ihtesham Rehman, Chair in Bioengineering at Lancaster University and senior author of the study, said: "This research is an important step in developing a new way to identify the chemical structures of different types of breast cancers. We have been able to use these 'fingerprints' to develop complex algorithms that are accurately able to identify cells of four different types of cancer types.

"Vibrational spectroscopy combined with data mining and machine learning has the potential to offer a real-time analysis in biological samples, including cancer, with excellent accuracy - creating a powerful new tool to sit alongside existing techniques and helping medical specialists deliver accurate and timely diagnosis for their patients, and for monitoring the progression of the disease."
-end-
The research has been outlined in the paper 'Advancing cancer diagnostics with artificial intelligence and spectroscopy: identifying chemical changes associated with breast cancer', which has been published in the journal Expert Review of Molecular Diagnostics.

The study's authors are Abdullah Talari and Ihtesham Rehman of Lancaster University and Shazza Rehman of Airedale NHS Foundation Trust.

Lancaster University

Related Breast Cancer Articles:

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
More Breast Cancer News and Breast Cancer Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#543 Give a Nerd a Gift
Yup, you guessed it... it's Science for the People's annual holiday episode that helps you figure out what sciency books and gifts to get that special nerd on your list. Or maybe you're looking to build up your reading list for the holiday break and a geeky Christmas sweater to wear to an upcoming party. Returning are pop-science power-readers John Dupuis and Joanne Manaster to dish on the best science books they read this past year. And Rachelle Saunders and Bethany Brookshire squee in delight over some truly delightful science-themed non-book objects for those whose bookshelves are already full. Since...
Now Playing: Radiolab

An Announcement from Radiolab